PDCD1 and hypothyroidism: Thyroid dysfunction, manifesting as hypothyroidism, thyrotoxicosis and thyroiditis, is the most common irAEs in the endocrine system, especially in anti-PD-1 therapy (Ferrari et al. 2018; Chang et al. 2019).